The proliferation of generic drugs, pressure on prices and the gradual emergence of personalized medicine have long been challenging traditional ways of operating in the Pharma industry. The Connected Factory 4.0 in which machines dialoguing through IoT are managed by a digital platform, vertically integrated to processes and through which data are produced and analyzed in real time, in self-learning mode through AI, represents a powerful vision.
The push toward establishing the Smart Factory model, through the introduction of digital enabling technologies, is correspondingly strong. A new model that will enable a revolutionary approach to efficiency, flexibility, quality, innovation and cost control.

The trend is now general, and it is no coincidence that, according to a multi-sector study by our partners at Cordence WorldWide, the priorities of CEOs and CFOs for the post-pandemic era includes digitization of all business areas at the top of the list. Pharma companies are certainly no exception in this landscape.

…